/

Ratio Therapeutics

Develops targeted radiopharmaceuticals for treating and imaging solid tumors.

BiotechnologyPharmaceuticals ratiotx.com ↗

Company facts

Founded: 2021
Employees: 58
Headquarters: United States
Type: Private
Funding: Series B · $50.7M · 2024